Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MYO10 |
| Upstream (Parents) |
|---|
| (<<) BCL2L1 → MYO10 |
| (<<) CD4 → MYO10 |
| (<<) CENPF → MYO10 |
| (<<) CHAF1A → MYO10 |
| (<<) E2F3 → MYO10 |
| (<<) EHD1 → MYO10 |
| (<<) GPX3 → MYO10 |
| (<<) HES1 → MYO10 |
| (<<) HLA-DOA → MYO10 |
| (<<) HLA-G → MYO10 |
| (<<) ITPR1 → MYO10 |
| (<<) LRP6 → MYO10 |
| (<<) NFIL3 → MYO10 |
| (<<) PTAFR → MYO10 |
| (<<) PTMA → MYO10 |
| (<<) PTPLA → MYO10 |
| (<<) RAC2 → MYO10 |
| (<<) RRAS → MYO10 |
| (<<) STAT1 → MYO10 |
| (<<) TAF9 → MYO10 |
| (<<) TINF2 → MYO10 |
| (<<) TMC7 → MYO10 |
| (<<) UBE2L6 → MYO10 |
| (<<) UBQLN2 → MYO10 |
| (<<) ZNF554 → MYO10 |
| Downstream (Children) |
|---|
| MYO10 → CCND3 (>>) |
| MYO10 → CDCP1 (>>) |
| MYO10 → ERRFI1 (>>) |
| MYO10 → FUT1 (>>) |
| MYO10 → INSR (>>) |
| MYO10 → MAFF (>>) |
| MYO10 → MTRR (>>) |
| MYO10 → NAGS (>>) |
| MYO10 → PARD6G (>>) |
| MYO10 → POP1 (>>) |
| MYO10 → SULT1A1 (>>) |
| MYO10 → TARS (>>) |
| MYO10 → YWHAG (>>) |
